Edwards Lifesciences

Yahoo Finance • 14 days ago

Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day

IRVINE, Calif., February 13, 2026--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in Citi’s Unplugged Medtech and Life Sciences Access Day on February 26, 2026. Scott Ullem, chief financia... Full story

Yahoo Finance • 16 days ago

Edwards Wavers Analysts Debate Its Earnings Miss Amid Hefty TAVR Investments

Edwards Lifesciences stock wavered Wednesday, though the heart-valve replacement maker issued a bullish outlook for 2026. Continue Reading... Full story

Yahoo Finance • 16 days ago

Edwards Lifesciences 2026 Growth Targets Achievable, RBC Says

Edwards Lifesciences' (EW) high-end guidance targets for 2026 are achievable given multiple catalyst PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 17 days ago

Edwards Lifesciences outlines 8%–10% sales growth and $2.90–$3.05 EPS guidance for 2026 while advancing SAPIEN and TMTT platforms

Earnings Call Insights: Edwards Lifesciences Corporation (EW) Q4 2025 MANAGEMENT VIEW * CEO Bernard Zovighian introduced Gerianne Sarte as the new Head of Investor Relations and stated, "We delivered a strong quarter, growing at 11.6%... Full story

Yahoo Finance • 17 days ago

Edwards Lifesciences Pops On Its Bullish 2026 View Despite Mixed Fourth Quarter

Edwards Lifesciences stock rose late Tuesday after earnings missed forecasts but fourth-quarter sales beat. Continue Reading... Full story

Yahoo Finance • 17 days ago

Edwards Lifesciences Reports Fourth Quarter Results

IRVINE, Calif., February 10, 2026--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2025. Highlights and Outlook Q4 sales grew 13.3% to $1.57 billion1, constan... Full story

Yahoo Finance • 18 days ago

Edwards Lifesciences Q4 2025 Earnings Preview

* Edwards Lifesciences (EW [https://seekingalpha.com/symbol/EW]) is scheduled to announce Q4 earnings results on Tuesday, February 10th, after market close. * The consensus EPS estimate is $0.62 [https://seekingalpha.com/symbol/EW/earn... Full story

Yahoo Finance • 24 days ago

Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026

IRVINE, Calif., February 03, 2026--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2025 after the market closes on Tuesday, February 10, and will host a conference... Full story

Yahoo Finance • 25 days ago

Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference

IRVINE, Calif., February 02, 2026--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 46th Annual Health Care Conference on Monday, Mar. 2, 2026. Scott Ullem, chief financial o... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences upgraded at JP Morgan on TAVR, TMTT strength

[Wall Street sign in Lower Manhattan, NYC] georgeclerk JP Morgan upgraded Edwards Lifesciences (EW [https://seekingalpha.com/symbol/EW]) to overweight from neutral highlighting accelerating growth in its transcatheter aortic valve replace... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., December 18, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026. Bernard Zovighian, chief executive offi... Full story

Yahoo Finance • 3 months ago

Sector Update: Health Care Stocks Lower Late Afternoon

Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 0.3% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 3 months ago

Edwards Lifesciences' (NYSE:EW) investors will be pleased with their 20% return over the last year

If you want to compound wealth in the stock market, you can do so by buying an index fund. But investors can boost returns by picking market-beating companies to own shares in. For example, the Edwards Lifesciences Corporation (NYSE:EW) sh... Full story

Yahoo Finance • 4 months ago

Notable healthcare headlines for the week: UNH, Eli Lilly and Merck in focus

Wall Street rallied higher as investors digested upbeat earnings from big tech companies during the week. The Nasdaq gained 2.2%, the S&P 500 moved up by 0.7%, and the Dow added 0.7% this week. However, the S&P 500 Health Care Index Sect... Full story

Yahoo Finance • 4 months ago

Closing Bell Movers: Amazon soars to all-time highs on earnings

In the opening hour of the evening session, U.S. equity futures are notably higher, with S&P 500 up 0.5% and Nasdaq 100 contracts up 1.0%.  In commodities, WTI Crude Oil is little changed just above $60 per barrel while precious metals are... Full story

Yahoo Finance • 4 months ago

Edwards Lifesciences raises 2025 guidance to high end of 9–10% sales growth and $2.56–$2.62 EPS amid strong Q3

Earnings Call Insights: Edwards Lifesciences (EW) Q3 2025 MANAGEMENT VIEW * CEO Bernard Zovighian opened the call by stating, "We are pleased with the year-to-date performance of the company, including the most recent third quarter, ou... Full story

Yahoo Finance • 4 months ago

Edwards Lifesciences Announces CFO Transition Plan

IRVINE, Calif., October 30, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that Scott Ullem, the company’s chief financial officer, has decided to transition from his role by midyear 2026. While the company initiate... Full story

Yahoo Finance • 4 months ago

Skyworks upgraded, UnitedHealth downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Piper Sandler upgraded Skyworks (SWKS)... Full story

Yahoo Finance • 4 months ago

EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE:... Full story

Yahoo Finance • 4 months ago

Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025

SAPIEN 3, which showed superiority at 1 year, also demonstrates compelling outcomes equivalent to surgery at seven years SAN FRANCISCO, October 27, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced seven-year data fro... Full story